565 Park Avenue New York, NY 10021
Manhattan: 212.860.0670 | Long Island: 516.466.2416


Archive for the ‘Injectables’ Category

Doctors React To Cosmetic Crime Wave

Thursday, August 5th, 2010 by editor2

In a string of several unrelated incidents, doctors in cities across the U.S., including Tampa, Fort Lauderdale, Dallas, Houston, Las Vegas and Newport Beach, report being ripped off by con-artists with expensive good looks.

Criminals targeting doctors’ offices and dubbed “Beauty Bandits” by popular media have made-over the old dine-and-dash routine and use it to steal thousands worth of cosmetic services from physicians.

These so-called bandits fill out new patient intake forms at doctors’ offices, giving fake names and phony contact information, then receive cosmetic treatments for facial rejuvenation and lip augmentation with injectables.

Treatment with a single injectable typically costs only a few hundred dollars in a single session, however cosmetic crooks often seek comprehensive treatment with a combination of injectables, such as Botox, Dysport, Juvederm, Radiesse and others.

After treatment is complete, “Beauty Bandits” claim they need to withdraw cash from an ATM, retrieve their purse from the car or check on a waiting child, then take off without paying their bill. More subtle forms of fraud are also used by patients who want a free ride, such as writing bad checks knowing there are insufficient funds to cover the cost of treatment.

“I’ve had it occur,” said Dallas plastic surgeon Dr. Rod Rohrich, Chairman of Plastic Surgery Department at UT Southwestern. “It’s mostly in patients I’ve never seen before. The best way [to prevent it] is to have all new patients pre-pay. In this way, we prevent the ‘runners,’ as we call them in Texas.”

Preventative approaches to this problem of bold theft and resulting revenue loss are catching on among physicians who offer cosmetic services, as greater numbers have begun asking that patients pre-pay for services using cash or a credit or debit card.

With upfront payment, not only can doctors protect their businesses, they can also devote their full attention to performing cosmetic procedures without being distracted by a nagging fear of being defrauded and foster a doctor-patient relationship built on trust, so don’t be offended if your first visit starts with a transaction.

Getting the business out of the way will allow you to relax and even enjoy working with your doctor to improve your appearance.

U.S. Anticipates Release of New Injectable Fillers and Wrinkle Relaxers

Thursday, July 15th, 2010 by editor2

Juvederm VolumaWithin the next year, a number of new injectable fillers and wrinkle-relaxing toxin competitors already being used in Europe are anticipated to become available in the U.S.

This is good news for doctors and patients in the U.S. because not only does the introduction of new injectable fillers and toxins on the market mean more options, improved product technology and better results, it also typically means more competition and lower prices.

Some next generation hyaluronic acid (HA) injectable fillers that are rumored to be contenders for the U.S. marketplace include:

  • Belotero (Merz) – Hyaluronic acid filler available in soft, basic and intense formulas
  • SubQ & Voluma (Medicis & Allergan) – Thicker, heavier HA fillers for contouring larger areas
  • Restylane Vital & Juvederm Hydrate (Medicis & Allergan) – Thinner, lighter HA fillers for areas that have been historically difficult to correct
  • Derma Veil (Medinter) – A pure collagen stimulator similar to Sculptra Aesthetic
  • Novabel (Merz) – Filler formulation derived from brown sea algae

More plumping, less lumping

Belotero, an HA filler similar to Juvederm that is less likely to cause post-injection lumps and bumps, has already been filed with the Food and Drug Administration (FDA), and may be available later this year.

SubQ and Voluma are large volume injectables used for facial contouring, such as chin augmentation and cheek augmentation, throughout Europe. Derma Veil is also used for cheek augmentation and restoring facial volume by increasing collagen production.

Unlike the other fillers used for adding volume to large facial areas, SubQ is also reportedly used by some for breast augmentation and buttock augmentation.

Innovative fillers for hard-to-treat areas

The lighter HA fillers being introduced by Medicis and Allergan, Restylane Vital and Juvederm Hydrate, are ideally suited to treat areas that have been historically difficult to correct with fillers, such as the back of hands, décolleté and neck.

These fillers also purport to increase skin hydration and elasticity to offer wrinkle prevention effects, and Restylane Vital even boasts a specialized automatic injection pen that regulates product injection volume and speed for more precise results.

While Restylane Vital may offer the most advanced injection technology, Novabel certainly offers the most unique composition and formulation of the new injectable fillers.

Unique formula for thin skin

Novabel’s biocompatible alginate composition is said to make injection easier and reduce swelling, while the patented Geleon technology used in its formulation reportedly improves skin elasticity. These factors make Novabel ideal for adding volume to facial areas with thin skin, such as the eyelids and tear troughs.

Better than Botox?

In addition to the European injectable filler products being considered for U.S. crossover, two new botulinum toxin type A products that may offer an advantage over Botox and Dysport are poised for introduction to the U.S. marketplace as well.

Theoretically, Xeomin, made by Merz, and PurTox, made by Mentor, would offer the same wrinkle-relaxing properties as Botox and Dysport, but with decreased chance of allergic reaction and development of blocking antibodies in patients. Xeomin and PurTox may also work faster and last longer than Botox and Dysport, however these theoretical benefits have not yet been proven.

Botox Studied as Potential Treatment for Tennis Elbow

Monday, April 26th, 2010 by newseditor

Researchers in Tehran have been studying the use of Botulinum toxin as a treatment for lateral epicondylitis, a condition commonly known as “tennis elbow.”

The study is published in the latest issue of the journal of the Canadian Medical Association. At the Imam Khomeini Hospital Complex in Tehran, a randomized placebo-controlled trial was conducted with 48 patients. They were injected with either Botox or saline, the placebo. Injection sites were customized for each patient’s anatomy.

When Botox injections were performed with anatomic measurements as a guide, they “significantly reduced pain at rest in patients with chronic refractory lateral epicondylitis.” However, doctors caution that because of side effects, the treatment may not be appropriate for patients who require finger extension.


Sign up for email-only specials!
First:
Invalid Input
Last:
Invalid Input
E-mail:
Invalid Input
Security Code: Security Code
Invalid Input
Translate this website